Q&A: Digital health startups need to rethink their stories to raise in 2023

Bill Taranto, president of Merck Global Health Innovation Fund, talks about the funding environment and how digital health companies can ensure investment this year. In 2021, investments in digital healthcare reached a peak, but funding has since sharply decreased. In an interview with MobiHealthNews, Bill Taranto, head of the Merck Global Health Innovation Fund, explains why Merck is interested in investing in digital health and what areas health technology businesses should concentrate on to attract venture capital funds in 2023. MobiHealthNews: When evaluating an investment, what qualities do you look for in a digital health company? Invoice Taranto: So, our investing theory can be divided into three sections. The first is that, in the future healthcare industry, we have this idea that data is valuable. Hence, in principle, we want all of our businesses to be data firms. Second, point solutions are ineffective.